Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1980 Jul;56(657):459–473. doi: 10.1136/pgmj.56.657.459

Paracetamol.

T J Meredith, R Goulding
PMCID: PMC2425823  PMID: 7003571

Abstract

Paracetamol is an analgesic and antipyretic agent which was first marketed for use as a drug in the U.K. in 1956. It has since become popular with the medical profession and the general public as an alternative to aspirin.

Full text

PDF
459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews R. S., Bond C. C., Burnett J., Saunders A., Watson K. Isolation and identification of paracetamol metabolites. J Int Med Res. 1976;4(4 Suppl):34–39. doi: 10.1177/14732300760040S408. [DOI] [PubMed] [Google Scholar]
  2. Antlitz A. M., Awalt L. F. A double blind study of acetaminophen used in conjunction with oral anticoagulant therapy. Curr Ther Res Clin Exp. 1969 Jun;11(6):360–361. [PubMed] [Google Scholar]
  3. Antlitz A. M., Mead J. A., Jr, Tolentino M. A. Potentiation of oral anticoagulant therapy by acetaminophen. Curr Ther Res Clin Exp. 1968 Oct;10(10):501–507. [PubMed] [Google Scholar]
  4. BRODIE B. B., AXELROD J. The fate of acetophenetidin in man and methods for the estimation of acetophenetidin and its metabolites in biological material. J Pharmacol Exp Ther. 1949 Sep;97(1):58–67. [PubMed] [Google Scholar]
  5. Barker J. D., Jr, de Carle D. J., Anuras S. Chronic excessive acetaminophen use and liver damage. Ann Intern Med. 1977 Sep;87(3):299–301. doi: 10.7326/0003-4819-87-3-299. [DOI] [PubMed] [Google Scholar]
  6. Benedetti M. S., Louis A., Malnoe A. Prevention of paracetamol-induced liver damage in mice with glutathione. J Pharm Pharmacol. 1975 Aug;27(8):629–632. doi: 10.1111/j.2042-7158.1975.tb09524.x. [DOI] [PubMed] [Google Scholar]
  7. Bonkowsky H. L., Mudge G. H., McMurtry R. J. Chronic hepatic inflammation and fibrosis due to low doses of paracetamol. Lancet. 1978 May 13;1(8072):1016–1018. doi: 10.1016/s0140-6736(78)90740-7. [DOI] [PubMed] [Google Scholar]
  8. Boyd E. M., Bereczky G. M. Liver necrosis from paracetamol. Br J Pharmacol Chemother. 1966 Mar;26(3):606–614. doi: 10.1111/j.1476-5381.1966.tb01841.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carson D. J. Fatal dextropropoxyphene poisoning in Northern Ireland. Review of 30 cases. Lancet. 1977 Apr 23;1(8017):894–897. doi: 10.1016/s0140-6736(77)91212-0. [DOI] [PubMed] [Google Scholar]
  10. Castro J. A., De Ferreyra E. C., De Castro C. R., Díaz Gómez M. I., D'Acosta N., De Fenos O. M. Studies on the mechanism of cystamine prevention of several liver structural and biochemical alterations caused by carbon tetrachloride. Toxicol Appl Pharmacol. 1973 Jan;24(1):1–19. doi: 10.1016/0041-008x(73)90176-2. [DOI] [PubMed] [Google Scholar]
  11. Clark R., Borirakchanyavat V., Davidson A. R., Thompson R. P., Widdop B., Goulding R., Williams R. Hepatic damage and death from overdose of paracetamol. Lancet. 1973 Jan 13;1(7794):66–70. doi: 10.1016/s0140-6736(73)90466-2. [DOI] [PubMed] [Google Scholar]
  12. Clark R., Borirakchanyavat V., Gazzard B. G., Rake M. O., Shilkin K. B., Flute P. T., Williams R. Disorderd hemostasis in liver damage from paracetamol overdose. Gastroenterology. 1973 Nov;65(5):788–795. [PubMed] [Google Scholar]
  13. Clark W. G., Moyer S. G. The effects of acetaminophen and sodium salicylate on the release and activity of leukocytic pyrogen in the cat. J Pharmacol Exp Ther. 1972 Apr;181(1):183–191. [PubMed] [Google Scholar]
  14. Cranston W. I. Central mechanisms of fever. Fed Proc. 1979 Jan;38(1):49–51. [PubMed] [Google Scholar]
  15. Cummings A. J., King M. L., Martin B. K. A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. Br J Pharmacol Chemother. 1967 Feb;29(2):150–157. doi: 10.1111/j.1476-5381.1967.tb01948.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Davidson A. R., Rojas-Bueno A., Thompson R. P., Williams R. Early unconjugated hyperbilirubinaemia after paracetamol overdosage. Scand J Gastroenterol. 1976;11(6):623–628. [PubMed] [Google Scholar]
  17. Davidson D. G., Eastham W. N. Acute liver necrosis following overdose of paracetamol. Br Med J. 1966 Aug 27;2(5512):497–499. doi: 10.1136/bmj.2.5512.497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Davis D. C., Potter W. Z., Jollow D. J., Mitchell J. R. Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci. 1974 Jun 1;14(11):2099–2109. doi: 10.1016/0024-3205(74)90092-7. [DOI] [PubMed] [Google Scholar]
  19. Davis M., Ideo G., Harrison N. G., Williams R. Early inhibition of hepatic bilirubin conjugation after paracetamol (acetaminophen) administration in the rat. Digestion. 1975;13(1-2):42–48. doi: 10.1159/000197694. [DOI] [PubMed] [Google Scholar]
  20. Davis M., Simmons C. J., Harrison N. G., Williams R. Paracetamol overdose in man: relationship between pattern of urinary metabolites and severity of liver damage. Q J Med. 1976 Apr;45(178):181–191. [PubMed] [Google Scholar]
  21. Dinarello C. A. Production of endogenous pyrogen. Fed Proc. 1979 Jan;38(1):52–56. [PubMed] [Google Scholar]
  22. Dinarello C. A., Wolff S. M. Pathogenesis of fever in man. N Engl J Med. 1978 Mar 16;298(11):607–612. doi: 10.1056/NEJM197803162981107. [DOI] [PubMed] [Google Scholar]
  23. Dixon M. F., Nimmo J., Prescott L. F. Experimental paracetamol-induced hepatic necrosis: a histopathological study. J Pathol. 1971 Apr;103(4):225–229. doi: 10.1002/path.1711030404. [DOI] [PubMed] [Google Scholar]
  24. Dordoni B., Willson R. A., Thompson R. P., Williams R. Reduction of absorption of paracetamol by activated charcoal and cholestyramine: a possible therapeutic measure. Br Med J. 1973 Jul 14;3(5871):86–87. doi: 10.1136/bmj.3.5871.86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Douglas A. P., Hamlyn A. N., James O. Controlled trial of cysteamine in treatment of acute paracetamol (acetaminophen) poisoning. Lancet. 1976 Jan 17;1(7951):111–115. doi: 10.1016/s0140-6736(76)93154-8. [DOI] [PubMed] [Google Scholar]
  26. Douglas A. P., Savage R. L., Rawlins M. D. Paracetamol (acetaminophen) kinetics in patients with Gilber's syndrome. Eur J Clin Pharmacol. 1978 May 31;13(3):209–212. doi: 10.1007/BF00609984. [DOI] [PubMed] [Google Scholar]
  27. Eden A. N., Kaufman A. Clinical comparison of three antipyretic agents. Am J Dis Child. 1967 Sep;114(3):284–287. doi: 10.1001/archpedi.1967.02090240098007. [DOI] [PubMed] [Google Scholar]
  28. Edwards O. M., Edwards P., Huskisson E. C., Taylor R. T. Paracetamol and renal damage. Br Med J. 1971 Apr 10;2(5753):87–89. doi: 10.1136/bmj.2.5753.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Eisner E. V., Shahidi N. T. Immune thrombocytopenia due to a drug metabolite. N Engl J Med. 1972 Aug 24;287(8):376–381. doi: 10.1056/NEJM197208242870803. [DOI] [PubMed] [Google Scholar]
  30. Farid N. R., Glynn J. P., Kerr D. N. Haemodialysis in paracetamol self-poisoning. Lancet. 1972 Aug 26;2(7774):396–398. doi: 10.1016/s0140-6736(72)91794-1. [DOI] [PubMed] [Google Scholar]
  31. Flower R. J., Vane J. R. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 1972 Dec 15;240(5381):410–411. doi: 10.1038/240410a0. [DOI] [PubMed] [Google Scholar]
  32. Forrest J. A., Adriaenssens P., Finlayson N. D., Prescott L. F. Paracetamol metabolism in chronic liver disease. Eur J Clin Pharmacol. 1979 Jul;15(6):427–431. doi: 10.1007/BF00561743. [DOI] [PubMed] [Google Scholar]
  33. Forrest J. A., Finlayson N. D., Adjepon-Yamoah K. K., Prescott L. F. Antipyrine, paracetamol, and lignocaine elimination in chronic liver disease. Br Med J. 1977 May 28;1(6073):1384–1387. doi: 10.1136/bmj.1.6073.1384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. GOULSTON K., SKYRING A. EFFECT OF PARACETAMOL (N-ACETYL-P-AMINOPHENOL) ON GASTROINTESTINAL BLEEDING. Gut. 1964 Oct;5:463–466. doi: 10.1136/gut.5.5.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. GWILT J. R., ROBERTSON A., GOLDMAN L., BLANCHARD A. W. The absorption characteristics of paracetamol tablets in man. J Pharm Pharmacol. 1963 Jul;15:445–453. doi: 10.1111/j.2042-7158.1963.tb12812.x. [DOI] [PubMed] [Google Scholar]
  36. Gazzard B. G., Ford-Hutchinson A. W., Smith M. J., Williams R. The binding of paracetamol to plasma proteins of man and pig. J Pharm Pharmacol. 1973 Dec;25(12):964–967. doi: 10.1111/j.2042-7158.1973.tb09987.x. [DOI] [PubMed] [Google Scholar]
  37. Gazzard B. G., Henderson J. M., Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut. 1975 Aug;16(8):617–620. doi: 10.1136/gut.16.8.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gazzard B. G., Hughes R. D., Portmann B., Dordoni B., Williams R. Protection of rats against the hepatotoxic effect of paracetamol. Br J Exp Pathol. 1974 Dec;55(6):601–605. [PMC free article] [PubMed] [Google Scholar]
  39. Gazzard B. G., Widdop B., Davis M., Hughes R. D., Goulding R., Williams R. Early prediction of the outcome of a paracetamol overdose based on an analysis of 163 patients. Postgrad Med J. 1977 May;53(619):243–247. doi: 10.1136/pgmj.53.619.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Gazzard B. G., Willison R. A., Weston M. J., Thompson R. P., Williams R. Charcoal haemoperfusion for paracetamol overdose. Br J Clin Pharmacol. 1974 Jun;1(3):271–275. doi: 10.1111/j.1365-2125.1974.tb00249.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Gerber J. G., MacDonald J. S., Harbison R. D., Villeneuve J. P., Wood A. J., Nies A. S. Effect of N-acetylcysteine on hepatic covalent binding of paracetamol (acetaminophen) Lancet. 1977 Mar 19;1(8012):657–658. doi: 10.1016/s0140-6736(77)92100-6. [DOI] [PubMed] [Google Scholar]
  42. HAJNAL J., SHARP J., POPERT A. J. A method for testing analgesics in rheumatoid arthritis using a sequential procedure. Ann Rheum Dis. 1959 Sep;18:189–206. doi: 10.1136/ard.18.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Hamlyn A. N., Douglas A. P., James O. F., Lesna M., Watson A. J. Liver function and structure in survivors of acetaminophen poisoning. A follow-up study of serum bile acids and liver histology. Am J Dig Dis. 1977 Jul;22(7):605–610. doi: 10.1007/BF01073078. [DOI] [PubMed] [Google Scholar]
  44. Hamlyn A. N., Douglas A. P., James O. The spectrum of paracetamol (acetaminophen) overdose: clinical and epidemiological studies. Postgrad Med J. 1978 Jun;54(632):400–404. doi: 10.1136/pgmj.54.632.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Hamlyn A. N. Paracetamol poisoning. Br Med J. 1978 Oct 14;2(6144):1089–1089. doi: 10.1136/bmj.2.6144.1089-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Harvey F., Goulding R. Letter: Action of cysteamine in paracetamol poisoning. Lancet. 1974 Nov 2;2(7888):1082–1082. doi: 10.1016/s0140-6736(74)92185-0. [DOI] [PubMed] [Google Scholar]
  47. Harvey J. G., Spooner J. B. Paracetamol poisoning. Br Med J. 1978 Sep 16;2(6140):832–833. doi: 10.1136/bmj.2.6140.832-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Heading R. C. Purpura and paracetamol. Br Med J. 1968 Sep 21;3(5620):743–744. doi: 10.1136/bmj.3.5620.743-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Howie D., Adriaenssens P. I., Prescott L. F. Paracetamol metabolism following overdosage: application of high performance liquid chromatography. J Pharm Pharmacol. 1977 Apr;29(4):235–237. doi: 10.1111/j.2042-7158.1977.tb11295.x. [DOI] [PubMed] [Google Scholar]
  50. Hughes R. D., Gazzard B. G., Hanid M. A., Trewby P. N., Murray-Lyon I. M., Davis M., Williams R., Bennet J. R. Controlled trial of cysteamine and dimercaprol after paracetamol overdose. Br Med J. 1977 Nov 26;2(6099):1395–1395. doi: 10.1136/bmj.2.6099.1395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Hughes R. D., Trewby P., Williams R. Letter: Cysteamine for paracetamol poisoning. Lancet. 1976 Mar 6;1(7958):536–536. doi: 10.1016/s0140-6736(76)90316-0. [DOI] [PubMed] [Google Scholar]
  52. Ivey R. J., Silvoso G. R., Krause W. J. Effect of paracetamol on gastric mucosa. Br Med J. 1978 Jun 17;1(6127):1586–1588. doi: 10.1136/bmj.1.6127.1586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Jagenburg O. R., Toczko K. The metabolism of acetophenetidine. Isolation and characterization of S-(1-acetamido-4-hydroxyphenyl)-cysteine, a metabolite of acetophenetidine. Biochem J. 1964 Sep;92(3):639–643. doi: 10.1042/bj0920639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Jagenburg R., Nagy A., Rödjer S. Separation of p-acetamidophenol metabolites by gel filtration on Sephadex G 10. Scand J Clin Lab Invest. 1968;22(1):11–16. doi: 10.3109/00365516809160729. [DOI] [PubMed] [Google Scholar]
  55. Johnson G. K., Tolman K. G. Chronic liver disease and acetaminophen. Ann Intern Med. 1977 Sep;87(3):302–304. doi: 10.7326/0003-4819-87-3-302. [DOI] [PubMed] [Google Scholar]
  56. Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther. 1973 Oct;187(1):195–202. [PubMed] [Google Scholar]
  57. Jollow D. J., Thorgeirsson S. S., Potter W. Z., Hashimoto M., Mitchell J. R. Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology. 1974;12(4-5):251–271. doi: 10.1159/000136547. [DOI] [PubMed] [Google Scholar]
  58. Kendal S. E., Lloyd-Jones G., Smith C. F. The development of a blood paracetamol estimation kit. J Int Med Res. 1976;4(4 Suppl):83–88. doi: 10.1177/14732300760040S415. [DOI] [PubMed] [Google Scholar]
  59. Kersh E. S. Treatment of propoxyphene overdosage with naloxone. Chest. 1973 Jan;63(1):112–114. doi: 10.1378/chest.63.1.112. [DOI] [PubMed] [Google Scholar]
  60. Kornberg A., Polliack A. Paracetamol-induced thrombocytopenia and haemolytic anaemia. Lancet. 1978 Nov 25;2(8100):1159–1159. doi: 10.1016/s0140-6736(78)92327-9. [DOI] [PubMed] [Google Scholar]
  61. Krikler D. M. Paracetamol and the kidney. Br Med J. 1967 Jun 3;2(5552):615–616. doi: 10.1136/bmj.2.5552.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. LASAGNA L. THE CLINICAL EVALUATION OF MORPHINE AND ITS SUBSTITUTES AS ANALGESICS. Pharmacol Rev. 1964 Mar;16:47–83. [PubMed] [Google Scholar]
  63. Levy G., Gwilt P. R. Activated charcoal for acute acetaminophen intoxication. JAMA. 1972 Jan 31;219(5):621–621. doi: 10.1001/jama.1972.03190310047020. [DOI] [PubMed] [Google Scholar]
  64. Loebl D. H., Craig R. M., Culic D. D., Ridolfo A. S., Falk J., Schmid F. R. Gastrointestinal blood loss. Effect of aspirin, fenoprofen, and acetaminophen in rheumatoid arthritis as determined by sequential gastroscopy and radioactive fecal markers. JAMA. 1977 Mar 7;237(10):976–981. doi: 10.1001/jama.237.10.976. [DOI] [PubMed] [Google Scholar]
  65. Lowenthal D. T., Oie S., Van Stone J. C., Briggs W. A., Levy G. Pharmacokinetics of acetaminophen elimination by anephric patients. J Pharmacol Exp Ther. 1976 Mar;196(3):570–578. [PubMed] [Google Scholar]
  66. Maclean D., Peters T. J., Brown R. A., McCathie M., Baines G. F., Robertson P. G. Treatment of acute paracetamol poisoning. Lancet. 1968 Oct 19;2(7573):849–852. doi: 10.1016/s0140-6736(68)91002-7. [DOI] [PubMed] [Google Scholar]
  67. Manor E., Marmor A., Kaufman S., Leiba H. Massive hemolysis caused by acetaminophen. Positive determination by direct Coombs test. JAMA. 1976 Dec 13;236(24):2777–2778. [PubMed] [Google Scholar]
  68. McLean A. E., Day P. A. The effect of diet on the toxicity of paracetamol and the safety of paracetamol-methionine mixtures. Biochem Pharmacol. 1975 Jan 1;24(1):37–42. doi: 10.1016/0006-2952(75)90310-x. [DOI] [PubMed] [Google Scholar]
  69. McMurtry R. J., Snodgrass W. R., Mitchell J. R. Renal necrosis, glutathione depletion, and covalent binding after acetaminophen. Toxicol Appl Pharmacol. 1978 Oct;46(1):87–100. doi: 10.1016/0041-008x(78)90139-4. [DOI] [PubMed] [Google Scholar]
  70. Meredith T. J., Newman B., Goulding R. Paracetamol poisoning in children. Br Med J. 1978 Aug 12;2(6135):478–479. doi: 10.1136/bmj.2.6135.478-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Miller R. P., Roberts R. J., Fischer L. J. Acetaminophen elimination kinetics in neonates, children, and adults. Clin Pharmacol Ther. 1976 Mar;19(3):284–294. doi: 10.1002/cpt1976193284. [DOI] [PubMed] [Google Scholar]
  72. Mitchell J. R. Host susceptibility and acetaminophen liver injury. Ann Intern Med. 1977 Sep;87(3):377–378. doi: 10.7326/0003-4819-87-3-377. [DOI] [PubMed] [Google Scholar]
  73. Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther. 1973 Oct;187(1):185–194. [PubMed] [Google Scholar]
  74. Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther. 1973 Oct;187(1):211–217. [PubMed] [Google Scholar]
  75. Mitchell J. R., McMurtry R. J., Statham C. N., Nelson S. D. Molecular basis for several drug-induced nephropathies. Am J Med. 1977 Apr;62(4):518–526. doi: 10.1016/0002-9343(77)90407-7. [DOI] [PubMed] [Google Scholar]
  76. Mitchell J. R., Thorgeirsson S. S., Potter W. Z., Jollow D. J., Keiser H. Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther. 1974 Oct;16(4):676–684. doi: 10.1002/cpt1974164676. [DOI] [PubMed] [Google Scholar]
  77. Moertel C. G., Ahmann D. L., Taylor W. F., Schwartau N. A comparative evaluation of marketed analgesic drugs. N Engl J Med. 1972 Apr 13;286(15):813–815. doi: 10.1056/NEJM197204132861504. [DOI] [PubMed] [Google Scholar]
  78. Moldéus P. Paracetamol metabolism and toxicity in isolated hepatocytes from rat and mouse. Biochem Pharmacol. 1978;27(24):2859–2863. doi: 10.1016/0006-2952(78)90201-0. [DOI] [PubMed] [Google Scholar]
  79. Mrochek J. E., Katz S., Christie W. H., Dinsmore S. R. Acetaminophen metabolism in man, as determined by high-resolution liquid chromatography. Clin Chem. 1974 Aug;20(8):1086–1096. [PubMed] [Google Scholar]
  80. Mudge G. H., Gemborys M. W., Duggin G. G. Covalent binding of metabolites of acetaminophen to kidney protein and depletion of renal glutathione. J Pharmacol Exp Ther. 1978 Jul;206(1):218–226. [PubMed] [Google Scholar]
  81. Nimmo J., Heading R. C., Tothill P., Prescott L. F. Pharmacological modification of gastric emptying: effects of propantheline and metoclopromide on paracetamol absorption. Br Med J. 1973 Mar 10;1(5853):587–589. doi: 10.1136/bmj.1.5853.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Nogen A. G., Bremner J. E. Fatal acetaminophen overdosage in a young child. J Pediatr. 1978 May;92(5):832–833. doi: 10.1016/s0022-3476(78)80169-3. [DOI] [PubMed] [Google Scholar]
  83. Nusynowitz M. L., Forsham P. H. The antidiuretic action of acetaminophen. Am J Med Sci. 1966 Oct;252(4):429–435. doi: 10.1097/00000441-196610000-00008. [DOI] [PubMed] [Google Scholar]
  84. Oie S., Lowenthal D. T., Briggs W. A., Levy G. Effect of hemodialysis on kinetics of acetaminophen elimination by anephric patients. Clin Pharmacol Ther. 1975 Dec;18(6):680–686. doi: 10.1002/cpt1975186680. [DOI] [PubMed] [Google Scholar]
  85. PHEAR E. A., RUEBNER B., SHERLOCK S., SUMMERSKILL W. H. Methionine toxicity in liver disease and its prevention by chlortetracycline. Clin Sci. 1956 Feb;15(1):93–117. [PubMed] [Google Scholar]
  86. Peterson G. R., Hostetler R. M., Lehman T., Covault H. P. Acute inhibition of oxidative drug metabolism by propoxyphene (Darvon). Biochem Pharmacol. 1979 Jun 1;28(11):1783–1789. doi: 10.1016/0006-2952(79)90541-0. [DOI] [PubMed] [Google Scholar]
  87. Pimstone B. L., Uys C. J. Liver necrosis and myocardiopathy following paracetamol overdosage. S Afr Med J. 1968 Mar 16;42(11):259–262. [PubMed] [Google Scholar]
  88. Piperno E., Berssenbruegge D. A. Reversal of experimental paracetamol toxicosis with N-acetylcysteine. Lancet. 1976 Oct 2;2(7988):738–739. doi: 10.1016/s0140-6736(76)90030-1. [DOI] [PubMed] [Google Scholar]
  89. Portmann B., Talbot I. C., Day D. W., Davidson A. R., Murray-Lyon I. M., Williams R. Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters. J Pathol. 1975 Nov;117(3):169–181. doi: 10.1002/path.1711170307. [DOI] [PubMed] [Google Scholar]
  90. Potter W. Z., Davis D. C., Mitchell J. R., Jollow D. J., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther. 1973 Oct;187(1):203–210. [PubMed] [Google Scholar]
  91. Prescott L. F. Analgesic abuse and renal disease in North-East Scotland. Lancet. 1966 Nov 26;2(7474):1143–1145. doi: 10.1016/s0140-6736(66)90469-7. [DOI] [PubMed] [Google Scholar]
  92. Prescott L. F. Haemodialysis in paracetomol self-poisoning. Lancet. 1972 Sep 23;2(7778):652–652. doi: 10.1016/s0140-6736(72)93038-3. [DOI] [PubMed] [Google Scholar]
  93. Prescott L. F., Newton R. W., Swainson C. P., Wright N., Forrest A. R., Matthew H. Successful treatment of severe paracetamol overdosage with cysteamine. Lancet. 1974 Apr 6;1(7858):588–592. doi: 10.1016/s0140-6736(74)92649-x. [DOI] [PubMed] [Google Scholar]
  94. Prescott L. F., Oswald I., Proudfoot A. T. Repeated self-poisoning with paracetamol. Br Med J. 1978 Nov 18;2(6149):1399–1399. doi: 10.1136/bmj.2.6149.1399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Prescott L. F., Park J., Ballantyne A., Adriaenssens P., Proudfoot A. T. Treatment of paracetamol (acetaminophen) poisoning with N-acetylcysteine. Lancet. 1977 Aug 27;2(8035):432–434. doi: 10.1016/s0140-6736(77)90612-2. [DOI] [PubMed] [Google Scholar]
  96. Prescott L. F., Park J., Proudfoot A. T. Letter: Cysteamine for paracetamol poisoning. Lancet. 1976 Feb 14;1(7955):357–357. doi: 10.1016/s0140-6736(76)90105-7. [DOI] [PubMed] [Google Scholar]
  97. Prescott L. F., Roscoe P., Wright N., Brown S. S. Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage. Lancet. 1971 Mar 13;1(7698):519–522. doi: 10.1016/s0140-6736(71)91125-1. [DOI] [PubMed] [Google Scholar]
  98. Prescott L. F., Stewart M. J., Proudfoot A. T. Cysteamine or N-acetylcysteine for paracetamol poisoning? Br Med J. 1978 Apr 1;1(6116):856–857. doi: 10.1136/bmj.1.6116.856-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Prescott L. F., Sutherland G. R., Park J., Smith I. J., Proudfoot A. T. Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet. 1976 Jul 17;2(7977):109–113. doi: 10.1016/s0140-6736(76)92842-7. [DOI] [PubMed] [Google Scholar]
  100. Prescott L. F. The third Lilly Prize Lecture. University of London, January, 1979. The nephrotoxicity and hepatotoxicity of antipyretic analgesics. Br J Clin Pharmacol. 1979 May;7(5):453–462. doi: 10.1111/j.1365-2125.1979.tb00986.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Prescott L. F., Wright N. Letter: B.A.L. in paracetamol poisoning. Lancet. 1974 Oct 5;2(7884):833–834. doi: 10.1016/s0140-6736(74)91092-7. [DOI] [PubMed] [Google Scholar]
  102. Prescott L. F., Wright N. The effects of hepatic and renal damage on paracetamol metabolism and excretion following overdosage. A pharmacokinetic study. Br J Pharmacol. 1973 Dec;49(4):602–613. doi: 10.1111/j.1476-5381.1973.tb08536.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. ROBBINS E. B. The pharmacologic effects of a new analgesic alpha-4-dimethylamino-1,2-diphenyl-3-methyl-4-propionyloxybutane. J Am Pharm Assoc Am Pharm Assoc. 1955 Aug;44(8):497–500. doi: 10.1002/jps.3030440812. [DOI] [PubMed] [Google Scholar]
  104. Rollins D. E., Buckpitt A. R. Liver cytosol catalyzed conjugation of reduced glutathione with a reactive metabolite of acetaminophen. Toxicol Appl Pharmacol. 1979 Feb;47(2):331–339. doi: 10.1016/0041-008x(79)90328-4. [DOI] [PubMed] [Google Scholar]
  105. Rosenberg D. M., Meyer A. A., Manning I. H., Jr, Neelon F. A. Acetaminophen and hepatic dysfunction in infectious mononucleosis. South Med J. 1977 Jun;70(6):660–661. doi: 10.1097/00007611-197706000-00007. [DOI] [PubMed] [Google Scholar]
  106. Rumack B. H., Peterson R. G. Acetaminophen overdose: incidence, diagnosis, and management in 416 patients. Pediatrics. 1978 Nov;62(5 Pt 2 Suppl):898–903. [PubMed] [Google Scholar]
  107. Sanerkin N. G. Acute myocardial necrosis in paracetamol poisoning. Br Med J. 1971 Aug;3(5772):478–478. doi: 10.1136/bmj.3.5772.478. [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Scheinberg I. H. Thrombocytopenic reaction to aspirin and acetaminophen. N Engl J Med. 1979 Mar 22;300(12):678–678. doi: 10.1056/nejm197903223001215. [DOI] [PubMed] [Google Scholar]
  109. Siegers C. P., Strubelt O., Schütt A. Relations between hepatotoxicity and pharmacokinetics of paracetamol in rats and mice. Pharmacology. 1978;16(5):273–278. doi: 10.1159/000136779. [DOI] [PubMed] [Google Scholar]
  110. Skokan J. D., Hewlett J. S., Hoffman G. C. Thrombocytopenic purpura associated with ingestion of acetaminophen (Tylenol). Cleve Clin Q. 1973 Summer;40(2):89–91. doi: 10.3949/ccjm.40.2.89. [DOI] [PubMed] [Google Scholar]
  111. Slattery J. T., Levy G. Acetaminophen kinetics in acutely poisoned patients. Clin Pharmacol Ther. 1979 Feb;25(2):184–195. doi: 10.1002/cpt1979252184. [DOI] [PubMed] [Google Scholar]
  112. Slattery J. T., Levy G. Reduction of acetaminophen toxicity by sodium sulfate in mice. Res Commun Chem Pathol Pharmacol. 1977 Sep;18(1):167–170. [PubMed] [Google Scholar]
  113. Smith J. M., Roberts W. O., Hall S. M., White T. A., Gilbertson A. A. Late treatment of paracetamol poisoning with mercaptamine. Br Med J. 1978 Feb 11;1(6109):331–333. doi: 10.1136/bmj.1.6109.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Spooner J. B., Harvey J. G. Paracetamol poisoning. Br Med J. 1978 Nov 11;2(6148):1369–1369. doi: 10.1136/bmj.2.6148.1369-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Strubelt O., Siegers C. P., Schütt A. The curative effects of cysteamine, cysteine, and dithiocarb in experimental paracetamol poisoning. Arch Toxicol. 1974;33(1):55–64. doi: 10.1007/BF00297053. [DOI] [PubMed] [Google Scholar]
  116. Szabo S., Cameron A. J. Acetaminophen (paracetamol) poisoning: gastrointestinal side effects of cysteamine and their possible cause and treatment. Mayo Clin Proc. 1977 Jun;52(6):402–402. [PubMed] [Google Scholar]
  117. Tarala R., Forrest J. A. Treatment of dextropropoxyphene poisoning. Br Med J. 1973 Jun 2;2(5865):550–550. doi: 10.1136/bmj.2.5865.550-c. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Thomson J. S., Prescott L. F. Liver damage and impaired glucose tolerance after paracetamol overdosage. Br Med J. 1966 Aug 27;2(5512):506–507. doi: 10.1136/bmj.2.5512.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Tomaszewski J. E., Jerina D. M., Daly J. W. Deuterium isotope effects during formation of phenols by hepatic monoxygenases. Evidence for an alternative to arene oxide pathway. Biochemistry. 1975 May 6;14(9):2024–2031. doi: 10.1021/bi00680a033. [DOI] [PubMed] [Google Scholar]
  120. Turk J. L. Contribution of modern immunological concepts to an understanding of diseases of the skin. Br Med J. 1970 Aug 15;3(5719):363–368. doi: 10.1136/bmj.3.5719.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Weston M. J., Talbot I. C., Horoworth P. J., Mant A. K., Capildeo R., Williams R. Frequency of arrhythmias and other cardiac abnormalities in fulminant hepatic failure. Br Heart J. 1976 Nov;38(11):1179–1188. doi: 10.1136/hrt.38.11.1179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Widdop B. The paracetamol test-kit in practice. J Int Med Res. 1976;4(4 Suppl):89–92. doi: 10.1177/14732300760040S416. [DOI] [PubMed] [Google Scholar]
  123. Willson R. A., Thompson R. P., Winch J., Williams R. Rapid removal of paracetamol by haemoperfusion through coated charcoal. In vivo and in-vitro studies in the pig. Lancet. 1973 Jan 13;1(7794):77–79. doi: 10.1016/s0140-6736(73)90470-4. [DOI] [PubMed] [Google Scholar]
  124. Wilson J. T., Kasantikul V., Harbison R., Martin D. Death in an adolescent following an overdose of acetaminophen and phenobarbital. Am J Dis Child. 1978 May;132(5):466–473. doi: 10.1001/archpedi.1978.02120300026004. [DOI] [PubMed] [Google Scholar]
  125. Winchester J. F., Edwards R. O., Tilstone W. J., Woodcock B. G. Activated charcoal hemoperfusion and experimental acetaminophen poisoning. Toxicol Appl Pharmacol. 1975 Jan;31(1):120–127. doi: 10.1016/0041-008x(75)90059-9. [DOI] [PubMed] [Google Scholar]
  126. Wrights N., Prescott L. F. Potentiation by previous drug therapy of hepatotoxicity following paracetamol overdosage. Scott Med J. 1973 Mar;18(2):56–58. doi: 10.1177/003693307301800205. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES